Search Results - "Rink, Michael"

Refine Results
  1. 1
  2. 2

    Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond—A Comprehensive Review of the Current Literature by Oing, Christoph, Rink, Michael, Oechsle, Karin, Seidel, Christoph, von Amsberg, Gunhild, Bokemeyer, Carsten

    Published in The Journal of urology (01-02-2016)
    “…Purpose We comprehensively reviewed current efforts and advances in the field of chemotherapeutic and biologically targeted treatment options after the failure…”
    Get full text
    Journal Article
  3. 3

    Urothelial carcinoma of the bladder and the upper tract: disparate twins by Green, David A, Rink, Michael, Xylinas, Evanguelos, Matin, Surena F, Stenzl, Arnulf, Roupret, Morgan, Karakiewicz, Pierre I, Scherr, Douglas S, Shariat, Shahrokh F

    Published in The Journal of urology (01-04-2013)
    “…Urothelial carcinoma of the bladder is the 4th most common malignancy in men and the 8th most common cause of male cancer death in the United States…”
    Get more information
    Journal Article
  4. 4

    Effect of Smoking on Outcomes of Urothelial Carcinoma: A Systematic Review of the Literature by Crivelli, Joseph J, Xylinas, Evanguelos, Kluth, Luis A, Rieken, Malte, Rink, Michael, Shariat, Shahrokh F

    Published in European urology (01-04-2014)
    “…Abstract Context Cigarette smoking is the best-established risk factor for urothelial carcinoma (UC). However, the effect of smoking on outcomes of UC patients…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy by von Haxthausen, Franziska, Reinhard, Linda, Pinnschmidt, Hans O, Rink, Michael, Soave, Armin, Hoxha, Elion, Stahl, Rolf A K

    Published in Frontiers in immunology (20-12-2018)
    “…Membranous nephropathy (MN) is an autoimmune disease caused by binding of circulating antibodies to podocyte antigens in the kidney. For decades and still…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC) by Bergmann, Sonja, Coym, Anja, Ott, Leonie, Soave, Armin, Rink, Michael, Janning, Melanie, Stoupiec, Malgorzata, Coith, Cornelia, Peine, Sven, von Amsberg, Gunhild, Pantel, Klaus, Riethdorf, Sabine

    Published in Oncoimmunology (01-01-2020)
    “…Immune checkpoint inhibition (ICI) of the PD-1/PD-L1 axis shows durable responses in a subset of patients with metastatic urothelial carcinoma (UC). However,…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy by Klatte, Tobias, Seitz, Christian, Rink, Michael, Rouprêt, Morgan, Xylinas, Evanguelos, Karakiewicz, Pierre, Susani, Martin, Shariat, Shahrokh F

    Published in The Journal of urology (01-11-2015)
    “…Purpose ERCC1 is the key enzyme of the nucleotide excision repair pathway, which maintains genomic stability. ERCC1 has been proposed as a prognostic and…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry by Boegemann, Martin, Schlack, Katrin, Rink, Michael, Bernhardt, Stephan, Moran, Michael, Hubbe, Marcus, Bergmann, Lothar, Schmid, Marianne, Strauss, Arne

    Published in Future oncology (London, England) (01-12-2020)
    “…Examine the effects of baseline hypertension (HTN) and statin or proton pump inhibitor (PPI) use on sunitinib treatment outcomes in STAR-TOR, a real-world…”
    Get full text
    Journal Article
  18. 18

    Smoking and smoking cessation effects on oncological outcomes in nonmuscle invasive bladder cancer by Simonis, Kathrin, Shariat, Shahrokh F, Rink, Michael

    Published in Current opinion in urology (01-09-2014)
    “…PURPOSE OF REVIEWCigarette smoking is the best established risk factor for the development of bladder cancer. Nevertheless, the impact of smoking and smoking…”
    Get full text
    Journal Article
  19. 19

    Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review by Aziz, Atiqullah, Dobruch, Jakub, Hendricksen, Kees, Kluth, Luis A., Necchi, Andrea, Noon, Aidan, Rink, Michael, Roghmann, Florian, Seiler, Roland, Gontero, Paolo, Kassouf, Wassim, Shariat, Shahrokh F., Xylinas, Evanguelos

    Published in World journal of urology (01-09-2017)
    “…Purpose To evaluate the role of neoadjuvant (NAC) and adjuvant chemotherapy (AC) in patients with upper tract urothelial carcinoma (UTUC) treated with radical…”
    Get full text
    Journal Article
  20. 20

    Development of Accurate Models for Individualized Prediction of Survival After Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma by Margulis, Vitaly, Shariat, Shahrokh F, Rapoport, Yury, Rink, Michael, Sjoberg, Daniel D, Tannir, Nizar M, Abel, E. Jason, Culp, Stephen H, Tamboli, Pheroze, Wood, Christopher G

    Published in European urology (01-05-2013)
    “…Abstract Background There is limited evidence to guide patient selection for cytoreductive nephrectomy (CN) following the diagnosis of metastatic renal cell…”
    Get full text
    Journal Article